Cloud Banner

Pharmaceutical

Image

Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market, By Therapeutic Application (Oncology, Autoimmune or Inflammatory), Application (Genome Engineering, Disease Models, Functional Genomics and Others), Technology (CRISPR or Cas9, Zinc Finger Nucleases  and Others),  Services (Design Tools, Plasmid and Vector, Cas9 and g-RNA, Delivery System Products and Others), Products (GenCrispr or Cas9 kits, GenCrispr Cas9 Antibodies, GenCrispr Cas9 Enzymes and Others), End-Users (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations and Others) - Industry Trends and Forecast to 2030.

Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Analysis and Size

Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is referred to as a genome editing technology that permits the genetic material to be added, altered and removed in an organism's DNA. CRISPR has revolutionized the field of gene therapy by enabling much more accurate gene editing and thus the prevention and treatment of human diseases. Key biomedical applications for CRISPR include gene therapy, drug discovery, and diagnostics. Various clinical studies on gene therapy are currently underway around the world.

Data Bridge Market Research analyses that the Clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing Market which was USD 1.09 billion in 2022, would reach up to USD 14.80 billion by 2030, and is expected to undergo a CAGR of 29.80% during the forecast period. “Oncology” dominates the therapeutic application segment of the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market owing to the higher prevalence of cancer. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Therapeutic Application (Oncology, Autoimmune or Inflammatory), Application (Genome Engineering, Disease Models, Functional Genomics and Others), Technology (CRISPR or Cas9, Zinc Finger Nucleases  and Others),  Services (Design Tools, Plasmid and Vector, Cas9 and g-RNA, Delivery System Products and Others), Products (GenCrispr or Cas9 kits, GenCrispr Cas9 Antibodies, GenCrispr Cas9 Enzymes and Others), End-Users (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations and Others

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Applied StemCell (U.S.), ACEA BIO (U.S.), Synthego (U.S.), Thermo Fisher Scientific (U.S.), GenScript (China), Addgene (U.S.), Merck KGaA (Germany), Intellia Therapeutics, Inc. (U.S.), Cellectis (France), Precision Biosciences (U.S.), Caribou Biosciences, Inc. (U.S.), Transposagen Biopharmaceuticals, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Novartis AG (Switzerland), New England Biolabs (U.S.), Rockland Immunochemicals Inc. (U.S.), ToolGen, Inc. (South Korea), TAKARA BIO INC. (Japan), Agilent Technologies, Inc. (U.S.), Abcam plc (U.K.), CRISPR Therapeutics AG (Switzerland)

Market Opportunities

  • Rising therapeutic applications
  • Drug discovery and development

Market Definition

CRISPR gene editing is a revolutionary molecular tool that allows precise modification of an organism's DNA. It employs a guided RNA molecule to target specific genetic sequences, directing a protein called Cas9 to make changes such as adding, deleting, or replacing DNA segments. This technology has vast applications in medicine, biotechnology, and agriculture, enabling the correction of genetic mutations, development of new therapies, and creation of genetically modified organisms. CRISPR has transformed genetic research and holds promise for treating genetic diseases and advancing various industries.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Dynamics

Drivers

  • Advancements in Gene Editing Technology

Continuous improvements and innovations in CRISPR technology, such as the development of more precise and efficient Cas proteins, enhance its utility for a wide range of applications

  • Potential for Treating Genetic Diseases

The ability to correct genetic mutations responsible for various diseases offers significant promise in the field of medicine, driving investment and research into CRISPR-based therapies

Opportunities

  • Rising Therapeutic Applications

CRISPR can be used to treat genetic disorders by correcting or replacing faulty genes. Targeted gene editing can also help develop more effective cancer treatments. With the growing research activities in CRISPR technology, many therapeutic applications of it can be unravelled

  • Drug Discovery and Development

CRISPR has the potential to accelerate the drug discovery process by creating disease models, screening for drug candidates, and validating drug targets

Restraint/Challenge

  • High Development Cost

Developing CRISPR-based therapies or applications can be expensive, particularly in the early stages of research and development. High costs associated with CRISPR gene editing may challenge the market in the forecast period

This clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In June 2022, Agilent Technologies Inc., a global leader in genomics technology, Leverages NVIDIA and AWS technology to improve analysis speeds of genomic bioinformatics pipeline

Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Scope

The clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market is segmented on the basis of therapeutic application, application, technology, services, products and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Therapeutic Application

  • Oncology
  • Autoimmune or Inflammatory

Application

  • Genome Engineering
  • Disease Models
  • Functional Genomics
  • Others

Technology

  • CRISPR or Cas9
  • Zinc Finger Nucleases
  • Others

Services

  • Design Tools
  • Plasmid and Vector
  • Cas9 and g-RNA
  • Delivery System Products
  • Others

Products

  • GenCrispr or Cas9 kits
  • GenCrispr Cas9 Antibodies
  • GenCrispr Cas9 Enzymes
  • Others

End-Users

  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Others

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Regional Analysis/Insights

The clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market is analysed and market size insights and trends are provided by therapeutic application, application, technology, services, products and end-user as referenced above.

The countries covered in the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market due to the considerable investments made by biotechnology and pharmaceutical companies. Furthermore, the rise in the healthcare infrastructure will further boost the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market due to the increasing of the per capita income. Moreover, the early accessibility of authorized therapies is further anticipated to propel the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Share Analysis

The clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing Market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market.

Some of the major players operating in the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market are:

  • Applied StemCell (U.S.)
  • ACEA BIO (U.S.)
  • Synthego (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • GenScript (China)
  • Addgene (U.S.)
  • Merck KGaA (Germany)
  • Intellia Therapeutics, Inc. (U.S.)
  • Cellectis (France)
  • Precision Biosciences (U.S.)
  • Caribou Biosciences, Inc. (U.S.)
  • Transposagen Biopharmaceuticals, Inc. (U.S.)
  • OriGene Technologies, Inc. (U.S.)
  • Novartis AG (Switzerland)
  • New England Biolabs (U.S.)
  • Rockland Immunochemicals Inc. (U.S.)
  • ToolGen, Inc. (South Korea)
  • TAKARA BIO INC. (Japan)
  • Agilent Technologies, Inc. (U.S.)
  • Abcam plc (U.K.)
  • CRISPR Therapeutics AG (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market will be worth USD 14.80 billion by 2030.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market growth rate is 29.80% during the forecast period.
Advancements in Gene Editing Technology & Potential for Treating Genetic Diseases are the growth drivers of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market.
The therapeutic application, application, technology, services, products and end-users are the factors on which the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market research is based.
The Agilent Technologies Inc., a global leader in genomics technology, Leverages NVIDIA and AWS technology to improve analysis speeds of genomic bioinformatics pipeline are the latest developments in the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials